Stockwinners Market Radar for August 20, 2024 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service

20:23 EDT Sunrun director Jurich sells 50,000 common shares - In a regulatory filing, Sunrun director Lynn Michelle Jurich disclosed the sale of 50,000 common shares of the company on August 19 at a price of $19.5001 per share.

18:49 EDT Regeneron says FDA issues CRL for BLA for linvoseltamab - Regeneron Pharmaceuticals announced that the U.S. FDA has issued a Complete Response Letter for the Biologics License Application for linvoseltamab in relapsed/refractory multiple myeloma that has progressed after at least three prior therapies. This anticipated outcome was previously disclosed during Regeneron's second quarter 2024 earnings call. The sole approvability issue identified is related to findings from a pre-approval inspection at a third-party fill/finish manufacturer for another company's product candidate. The third-party fill/finish manufacturer has since informed Regeneron that it believes the findings have been resolved, their facility is awaiting reinspection by the FDA, and it is expected to take place in the coming months. Regeneron is committed to working closely with the third-party fill/finish manufacturer and the FDA to bring linvoseltamab to appropriate patients with R/R MM as quickly as possible, which is critical because most MM patients relapse and ultimately require additional therapies in late-line settings.

17:56 EDT Dada Nexus names Kevin Qing Guo to succeed Ian Su Shan as chairman of the board - Dada Nexus announced that the board of directors has elected Kevin Qing Guo to become a director and a member of the compensation committee of the Board and succeed Mr. Ian Su Shan as the chairman of the Board, effective August 20, 2024. Ian Su Shan will continue to serve as a director of the Company and a member of the nominating and corporate governance committee of the Board. After the change, the Board will consist of six members, three of whom are independent directors. In addition, Bing Fu has notified the Board of his resignation as the Interim President of the Company for personal reasons, effective August 20, 2024. Meanwhile, the board of directors is actively evaluating the Company's leadership composition in light of the Company's long-term development plans.

17:31 EDT Lockheed Martin awarded $113.64M Navy contract modification - Lockheed Martin was awarded a $113.64M firm-fixed-price modification to a previously awarded contract for option exercise of full rate production Surface Electronic Warfare Improvement Program AN/SLQ-32(V)6 and AN/SLQ-32C(V) six systems. This contract combines purchases for the Navy, and the government of Japan, under the Foreign Military Sales program. Work is expected to be completed by October 2026. FY24 shipbuilding and conversion in the amount of $86.93M; FY24 FMS in the amount of $21.73M and FY24 other procurement funds in the amount of $4.99M, will be obligated at time of award and will not expire at the end of the current fiscal year. Naval Sea Systems Command is the contracting activity.

17:07 EDT Enerflex provides update on Kurdistan project - Enerflex provided an update of a modularized cryogenic natural gas processing facility in Kurdistan. As previously announced, and in response to a drone attack on April 26, that resulted in fatalities at an operational facility proximate to the EH Cryo project, Enerflex provided its customer with notice of force majeure, suspended activity at the project site, and demobilized its personnel. Since that time, Enerflex has worked with its customer to evaluate the situation and assess potential options to complete the project notwithstanding the prevailing security situation at the project site. Despite these efforts, Enerflex has received a notice that its customer intends to terminate the EH Cryo project contract with effect as of September 8. Enerflex views the purported termination as a wrongful attempt by its customer to circumvent Enerflex's contractual rights to suspend performance while the project site remains unsafe. Enerflex intends to dispute such wrongful purported termination and to protect its position in respect of the EH Cryo project. As of June 30, construction of the EH Cryo project was approximately 85% complete. Revenues associated with the EH Cryo project are recognized within Enerflex's Engineered Systems product line and any amounts not yet invoiced are presented as an unbilled revenue asset on Enerflex's consolidated statements of financial position. The net unbilled revenue asset recognized for the EH Cryo project was approximately $160M at the end of the second quarter. As at June 30, the EH Cryo project represented approximately 6% of the company's Engineered Systems backlog. The company has provided a $31M letter of credit in support of its obligations under the EH Cryo project contract, which financial security is funded with the company's revolving credit facility and LC Facility. As Enerflex views the customer's termination as improper, Enerflex would similarly view any drawing of such financial security in the prevailing circumstances as similarly improper.

17:04 EDT LivePerson founder Robert LoCascio nominates two candidates for board - Robert LoCascio, founder and former CEO of LivePerson and beneficial owner of approximately 2.4% of the outstanding shares of company common stock, announced that he has nominated two independent nominees for election to the LivePerson board of directors at the company's 2024 annual meeting of stockholders. LoCascio has filed a preliminary proxy statement with the SEC. LoCascio said, "The nominees, Walter Bachtiger, Founder and CEO of TimeTrust, a Silicon Valley FinTech company and former LivePerson Vice President, and Michal Czwarno, a strategic technology business leader with substantial experience in global strategy formation and execution, would bring much-needed AI industry and Business to Business ("B2B") experience to the Board. LivePerson was at one time a leading AI company, but since August 2023, the value of its stock has fallen by approximately 80%, including a 47% single-day drop following the Company's February 2024 earnings call in which management announced an unprecedented $100 million revenue loss due to customer churn. Further, Mr. LoCascio believes the Company undertook a debt restructuring plan in May 2024 that was dilutive to equity stockholders and increased the Company's covenants restrictions and exposure to interest rates. There are also notable recent departures of key employees, especially from the Company's data science team. The goal should be to reestablish LivePerson as a leading global provider in the conversational AI contact center space and the AI space overall.Mr. LoCascio believes that a refreshed Board, with a deep understanding of LivePerson's operations and the evolving market dynamics surrounding AI and the contact center sector, would allow the Company to regain a market-leading position and the confidence of its stockholders. Mr. LoCascio also believes that with the right strategic plan and Board composition, the Company can rapidly unlock the potential of its unique data and platform assets. Mr. LoCascio's Nominees bring the relevant expertise, experience and knowledge to return the Company to its historical strategy of innovation, and bring an important and currently lacking stockholder mentality to the Board."

17:02 EDT Aadi Bioscience to halt PRECISION1 trial of nab-sirolimus - Aadi Bioscience announced it will halt the registration-intended PRECISION1 trial of nab-sirolimus in patients with solid tumors harboring TSC1 or TSC2 inactivating alterations. An analysis by the Independent Data Monitoring Committee demonstrated that the study was unlikely to exceed an efficacy threshold necessary to support an accelerated approval, the key goal of this Phase 2 study. The approximately 25 patients in PRECISION1 who are still benefiting from nab-sirolimus will be eligible for transition to a planned expanded access protocol, and a complete analysis of the PRECISION1 trial will be provided at a later date. Aadi will now focus on preserving cash while maximizing its commercial business. Aadi's marketed product, FYARRO, is the only preferred treatment for patients with advanced malignant PEComa, a rare and aggressive cancer. In the second quarter of this year, FYARRO delivered sales of $6.2M. To further preserve cash runway, Aadi will pause new enrollment, but continue dosing previously enrolled patients, in two, ongoing Phase 2 trials of nab-sirolimus for advanced or recurrent endometrioid-type endometrial cancer and neuroendocrine tumors. Both studies have enrolled sufficient patients to assess initial efficacy signals later this year. Aligned to these pipeline adjustments, the company is reducing its Research & Development workforce by 80%. Together these actions extend cash runway into at least 2H 2026. "We are humbled by the effort of the investigators, support staff, and most importantly, the patients and their families who took part in PRECISION1. While nab-sirolimus showed monotherapy activity in the study population, the trial fell short of delivering what we believe would be required to support an accelerated approval in the broad TSC1/TSC2 inactivating mutations indication. We look forward to providing the full trial analysis at a later date," said David Lennon, President and CEO of Aadi Bioscience. "I want to thank the dedicated Aadi employees who worked tirelessly on this trial and are negatively impacted by this outcome. Given the change in the development pipeline, we have taken the necessary steps to immediately preserve cash runway, and have hired an advisory firm to explore all options to maximize value for shareholders."

16:52 EDT Hyatt to acquire Standard International and its brands - Hyatt Hotels announced the planned acquisition of the brands and most of the affiliates of pioneering lifestyle company Standard International, parent company of The Standard and Bunkhouse Hotels brands. This move enhances Hyatt's position as the leader in the industry's premier lifestyle space, building on both its organic growth and a series of acquisitions that quintupled the number of lifestyle rooms in Hyatt's global portfolio between 2017 and 2023. The transaction is anticipated to close later this year, subject to customary closing conditions. With this transaction, Hyatt will form a new dedicated lifestyle group that will be headquartered in New York City. Upon closing, the sale will cap a successful investment for Sansiri PLC, which acquired a majority position in Standard International in 2017 and facilitated the company's international expansion. Sansiri will continue to own several properties that will be managed or franchised under the acquired brands. Upon closing, Hyatt will pay a base purchase price of $150 million, with up to an additional $185 million over time as additional properties enter the portfolio. Stabilized fees associated with the base purchase price are anticipated to be approximately $17 million and, to the extent the contingent purchase price is paid, additional stabilized fees are anticipated to be up to approximately $30 million. In connection with the transaction, Moelis & Company LLC served as financial advisor to Hyatt and Venable LLP acted as its legal advisor.

16:41 EDT Agilysys announces acquisition of Book4Time for $150M cash - Agilysys, announced it has acquired Book4Time, "the global leader in spa management SaaS software, serving more Forbes 5-Star-rated spas than any other solution," according to a company statement. "As the top enterprise SaaS technology for wellness hospitality organizations, Book4Time manages guest experiences at spas, international hotels, resorts, casinos, golf and private member clubs in more than 100 countries. Hotel Tech Report, a hospitality technology customer ratings researcher, named Book4Time the 2024 HotelTechAward Winner for Best Spa Management Software. Acquiring Book4Time expands the opportunity for Agilysys to increase its solutions-per-customer penetration globally," added the release... Roger Sholanki, Book4Time Founder and Chief Executive Officer, commented, "Over the past 20 years, we have worked hand-in-hand with the world's leading hospitality brands in over 100 countries to develop the industry's #1 SaaS platform for spa and wellness operations. We are excited about the opportunity to join forces with the impressive Agilysys team and our shared vision to deliver High Return Hospitality. The technology innovation strengths of Agilysys and the broad range of state-of-the-art solutions in their portfolio, including membership and golf, exponentially elevates the value we can deliver to clients." The all-cash transaction closed for approximately $150M, subject to customary closing adjustments. Any impacts to the Company's financial guidance for the 2025 fiscal year along with further details will be discussed during the upcoming Agilysys fiscal 2025 second quarter earnings call in October 2024.

16:38 EDT BigBear.ai jumps 46% tot nearly $2 after announcing FAA contract

16:36 EDT Toll Brothers sees FY24 deliveries 10,650-10,750 units - Sees FY24 average delivered price per home $975,000. Sees FY24 tax rate 25.4%.

16:35 EDT Toll Brothers sees Q4 deliveries 3,275-3,375 units - Sees Q4 average delivered price per home $940,000-$950,000. Sees Q4 tax rate 26%.

16:33 EDT Altair Engineering rallies after Matrix Capital clarifies position - Shares of Altair Engineering are moving higher in after-hours trading after selling off most of the trading day. The rally followed a statement by Matrix Capital Management that it is maintaining its full position in Altair. The stock clawed back losses late in the trading day after Altair highlighted Matrix's statement in its own press release. They are up 6% in after-hours to $91.35. Matrix issued in a press release saying, "The partners of Matrix Capital Management have issued a statement to clarify their position regarding their holdings in Altair Engineering. Matrix Capital Management will continue to hold our full position in Altair Engineering, reaffirming our confidence in the company's long-term growth potential."

16:31 EDT Equus II Inc reports Q2 NAV per share $3.66 - Reports net assets as of June 30 of $49.8M.

16:28 EDT AllCity Network raises Series B led by Tegna - AllCity Network, the operator of multi-platform local sports networks, has raised its Series B funding. The round is led by public broadcast company, Tegna. Existing investors Mosaic General Partnership and Bullpen Capital also participated in the round. The Tegna investment brings AllCity Network's total funding beyond $25M and further accelerates the company's position within the digital sports industry. In addition to the investment, AllCity and Tegna have entered into a commercial agreement that encompasses cross-promotional opportunities, content licensing, revenue extension opportunities and distribution via Tegna station's linear channels and streaming apps in some of America's most important sports markets. Additionally, talent from AllCity and Tegna's Locked On Podcast Network will make guest appearances across each other's shows.

16:25 EDT Meta Data Ltd (ADR) trading halted, news dissemination

16:21 EDT Jewett-Cameron Trading Company Ltd. launches in-store fence product displays - Jewett-Cameron Trading Company Ltd. has successfully launched in-store merchandiser displays in major home improvement retailers for their integrated steel framework for wood fences. These displays were successfully trialed during our fiscal third quarter, expanded into more stores throughout the summer, with additional regions scheduled to be added in a larger roll-out during our first quarter which begins September 1, 2024. In the spring of 2024, Jewett Cameron collaborated with major home center retailers to develop a merchandise display with enhanced point-of-sale messaging to be located in-aisle near wood fence materials. The initial trial of these merchandisers in the Southern California region was so successful other stores quickly opted in. Lifetime Steel Post(R) product sales in participating stores with these merchandisers notably outperformed year over year. Regional merchant managers in other areas took notice and requested merchandisers to be added to their stores. Jewett Cameron currently has a number of other regions scheduled for merchandiser installation with additional region requests continuing to come in.

16:18 EDT Microchip says unauthorized party disrupted some business operations - In a regulatory filing, Microchip stated: "On August 17, 2024, Microchip Technology Incorporated detected potentially suspicious activity involving its information technology, or 'IT,' systems. Upon detecting the issue, the company began taking steps to assess, contain and remediate the potentially unauthorized activity. On August 19, 2024, the company determined that an unauthorized party disrupted the company's use of certain servers and some business operations. The company promptly took additional steps to address the incident, including isolating the affected systems, shutting down certain systems, and launching an investigation with the assistance of external cybersecurity advisors. As a result of the incident, certain of the company's manufacturing facilities are operating at less than normal levels, and the company's ability to fulfill orders is currently impacted. The company is working diligently to bring the affected portions of its IT systems back online, restore normal business operations and mitigate the impact of the incident. As the company's investigation is ongoing, the full scope, nature and impact of the incident are not yet known. As of the date of this filing, the company has not yet determined whether the incident is reasonably likely to materially impact the company's financial condition or results of operations." Reference Link

16:12 EDT Coca-Cola Consolidated increases quarterly dividend to $2.50 per share - Coca-Cola Consolidated announced that its board increased the company's quarterly dividend to $2.50 per share up from 50c per share. The increased dividend will be payable November 8 to common stock and Class B common stock stockholders of record as of October 25.

16:10 EDT N2OFF to pursue food waste carbon credit Verra VM00046 methodology - N2OFF announced its plan to utilize its subsidiary, Save Foods Ltd.'s "Save Foods" , patented treatment to extend shelf life of certain fruits and vegetables to pursue monetizing the quantification of emission reductions by keeping food in the human supply chain. If successful, the Company could receive designated food waste credit. Save Foods engaged a team of sustainability strategy experts from the Nibbana-Group, led by Galit Kenigsberg, to examine potential avenues to provide alternative revenue streams from Save Food's patented treatment. They concluded that Save Foods may meet the conditions of the Verra VM00046 methodology and could potentially be eligible to receive certain benefits such as food waste carbon credits.

16:04 EDT Leonardo DRS awarded $52M follow-on production order - Leonardo DRS announced that it has received an order for continued production of its advanced Sniper Weapon Sights for U.S. Army snipers. The recently awarded production order for $52M was made under the current Family of Weapon Sights-Sniper IDIQ contract. Incorporating DRS's proven cooled infrared imaging technology, FWS-S is a clip-on thermal weapon sight used in conjunction with existing daytime sniper optics to provide rapid target acquisition capabilities to the sniper during day and night. The sighting system gives users the ability to acquire targets in a range of difficult environmental conditions, including smoke or fog, providing strategic and tactical advantages to the sniper. "Ensuring soldiers have the most advanced technology on the battlefield today is critical, and the Family of Weapon Sights - Sniper answers that call," said Jerry Hathaway, senior vice president and general manager of DRS's Electro-Optical Infrared Systems business. "We are proud to provide this innovative technology, and proud the U.S. Army recognizes us as a trusted partner to continue delivering these systems to the frontline warfighters."

16:01 EDT Everspin awarded $14.55M to provide stable on-shore MRAM manufacturing - Everspin Technologies announced a strategic award to develop a long-term plan to provide manufacturing services for aerospace and defense segments. Under the award, Everspin will provide a plan to mitigate risks to its MRAM manufacturing supply chain. "Everspin is pleased to provide continuous on-shore MRAM capability to its aerospace and defense customers," said Sanjeev Aggarwal, President Technologies and CEO of Everspin Technologies. "Our MRAM manufacturing technology and integration is front-end CMOS agnostic allowing our customers and Everspin to source the optimal CMOS wafers from a FAB of choice." Everspin's MRAM manufacturing line in Chandler, Arizona will continue to support both current and future Department of Defense strategic and commercial space system requirements. The award is valued at $14.55M over 2.5 years.

15:59 EDT Altair says it appreciates Matrix Capital's decision to maintain full position - Altair responded to a statement from Matrix Capital Management. "In response to today's announcement from Matrix Capital Management, we appreciate its strong support over the years and its decision to maintain its full position in Altair, recognizing our long-term strategic value," said James R. Scapa, founder, chairman, and chief executive officer, Altair.

15:54 EDT U-BX Technology Ltd trading halted, volatility trading pause

15:03 EDT Take-Two announces 'Borderlands 4' coming in 2025 - 2K (TTWO) and Gearbox Software officially announced that Borderlands 4, the next entry in the looter-shooter franchise, will launch in 2025, during Take-Two's Fiscal Year 2026, on PlayStation 5 (SONY), Xbox Series X S (MSFT), and PC through Steam and the Epic Games Store. "We're thrilled to be able to share with our fans that 2025 will mark a massive year for 2K and Gearbox Entertainment. The Borderlands series is one of 2K's most successful franchises ever and is beloved by millions globally. We're excited that our already close partnership and collaboration with the Gearbox team has grown even deeper, and we look forward to delivering best-in-class experiences for both longtime fans and new players alike," said 2K Core Games Senior Vice President and General Manager Catharina Lavers Mallet.

14:57 EDT Amazon to debut 'King of Meat' online co-op combat game - "Amazon Games and Glowmade announcedsKing of Meat, a hacking, slashing, online co-op spectacle for one through four players, stepping into the role of fearless contenders battling through ridiculous dungeons. Set in the mystical world of Loregok, King of Meat takes players to a place of dragons, trolls, skeletons, and, of course, corporate commercialism - where high fantasy meets the glitz, glamor, and media-infatuation of modern-day celebrity. The focus of this obsession is the wildest survival gameshow imaginable, "KING OF MEAT."..King of Meat joins Amazon Games' growing portfolio, which includes New World and Lost Ark, both of which have topped Steam and Twitch charts and continue to nurture active player communities. Upcoming Amazon Games titles include THRONE AND LIBERTY, developed by NCSoft...," said Amazon on its Amazon Games blog. Reference Link

14:23 EDT Take-Two's Gearbox says 'Borderlands 4' coming in 2025 - Gearbox Entertainment tweeted: "BORDERLANDS 4 IS COMING 2025! We opened #ONL2024 with our BIG ANNOUNCEMENT- watch it again (and again, and again)!" In March, Take-Two announced that it entered into a definitive agreement with Embracer Group to acquire The Gearbox Entertainment Company. Reference Link

14:04 EDT Five9 announces plan to cut global full-time employees by 7%

14:01 EDT Yoshiharu Global Co trading resumes

13:42 EDT Cadrenal Therapeutics Inc trading halted, volatility trading pause

13:17 EDT Elliott 'commends' Texas Instruments on capital allocation update - Elliott Investment Management L.P. released a statement attributed to Managing Partner Jesse Cohn and Partner Jason Genrich regarding Texas Instruments: "We commend Texas Instruments on today's capital-allocation update, which re-affirms TI's long-standing commitment to shareholders that long-term growth of free cash flow per share is the Company's true north. During today's presentation, Texas Instruments presented a path to robust free cash flow generation across a range of revenue scenarios, including a path to $12 per share of free cash flow in 2026. Additionally, TI committed to a modular capex plan, with significant flexibility to dynamically calibrate capex beginning in 2026. As detailed in our May 28 letter to the Board, we are supportive of TI's strategy to build the world's largest footprint of US-based, 300-mm analog semiconductor capacity, and we believe today's update is well aligned with Elliott's proposed approach. We appreciate our ongoing, constructive dialogue with Texas Instruments, and we believe today's off-cycle capital-management event is another positive step toward the goal of long-term value creation for all shareholders."

13:11 EDT Torrid Holdings trading halted, volatility trading pause

12:42 EDT Cingulate Inc trading halted, volatility trading pause

12:00 EDT Ginkgo Bioworks falls -13.5% - Ginkgo Bioworks is down -13.5%, or -$1.26 to $8.10.

12:00 EDT Emergent BioSolutions falls -15.0% - Emergent BioSolutions is down -15.0%, or -$1.82 to $10.28.

12:00 EDT Amer Sports rises 12.5% - Amer Sports is up 12.5%, or $1.54 to $13.89.

11:34 EDT Emergent BioSolutions finalizes sale of Baltimore-Camden manufacturing site - Emergent BioSolutions has completed the sale of its drug product facility in Baltimore-Camden to an affiliate of Bora Pharmaceuticals. Emergent received approximately $30 million at closing, which is subject to customary post-closing adjustments. With the transaction closed, Bora has acquired the assets, equipment, and workforce associated with the 87,000 square foot Baltimore-Camden manufacturing facility.

10:35 EDT Harley says does not have DEI function, ended supplier diversity goals - Harley-Davidson, in a statement posted on X last night, said it is "saddened by the negativity on social media over the last few weeks, designed to divide the Harley-Davidson community." The company announced it does not have a diversity, equity and inclusion function today and that it no longer has supplier diversity spend goals. Reference Link

10:21 EDT Nerdy CEO buys 10.99M shares for $9.73M - Nerdy CEO Charles Cohn disclosed the purchase of 10.99M shares at an average price of 89c, for a total of $9.73M. Cohn now owns $33.75M shares of Nerdy. The stock in morning trading is down 4% to $1.03.

10:09 EDT Netflix says upfront ad sales commitments up 150% from 2023 - Netflix said in a blog post: "For Netflix's second year of Upfront negotiations, we closed deals with all major holding companies as well as independent agencies, with a 150% plus increase in upfront ad sales commitments over 2023, in-line with our expectations. Upfront commitments include investments from all key categories like CPG, Tech & Entertainment, Auto, QSR, and Retail. Netflix closed partnerships for a number of our upcoming films and series including fan-favorites Squid Game, Wednesday, Outer Banks, Happy Gilmore 2, Ginny & Georgia, and Love is Blind as well as deals around highly anticipated live events including WWE Raw, and the Christmas Day NFL games." Reference Link

10:02 EDT EU approves EUR 5B German state aid measure to support ESMC in setting up plant - The European Commission has approved, under EU State aid rules, a EUR 5B German measure to support European Semiconductor Manufacturing Company in the construction and operation of a microchip manufacturing plant in Dresden. ESMC is a joint venture between Taiwan Semiconductor Manufacturing Company (TSM), Bosch, Infineon (IFNNY), and NXP (NXPI). The measure will strengthen Europe's security of supply, resilience and digital sovereignty in semiconductor technologies, in line with the objectives set out in the European Chips Act Communication. The measure will also contribute to achieving the digital and green transitions. The new large-scale manufacturing facility supported under the measure will deliver high-performance chips, based on 300mm silicon wafers with node sizes covering 28/22nm and 16/12nm, using field-effect transistor technology and allowing the integration of several additional features in one chip. The produced chips will offer better performance while at the same time reducing total power consumption. The plant, which is planned to be operating at full capacity by 2029, is expected to produce 480,000 silicon wafers per year. Reference Link

10:01 EDT Eastman Chemical appoints Ike Adeyemi as CLO - Eastman Chemical Company (EMN) announced that Ike Adeyemi will join the company on Sept. 9, 2024, and will serve as Senior Vice President, Chief Legal Officer and Corporate Secretary. Adeyemi joins Eastman from The Clorox Company (CLX), where she served as vice president, corporate secretary, and associate general counsel since December 2020.

10:00 EDT ZKH Group rises 13.9% - ZKH Group is up 13.9%, or 50c to $4.10.

10:00 EDT Sunlands Online falls -7.0% - Sunlands Online is down -7.0%, or -64c to $8.54.

10:00 EDT Vipshop falls -11.6% - Vipshop is down -11.6%, or -$1.63 to $12.39.

09:48 EDT Emergent BioSolutions falls -6.1% - Emergent BioSolutions is down -6.1%, or -74c to $11.36.

09:48 EDT Navios Maritime Partners rises 8.9% - Navios Maritime Partners is up 8.9%, or $4.21 to $51.56.

09:47 EDT Fabrinet rises 13.6% - Fabrinet is up 13.6%, or $31.40 to $262.95.

09:38 EDT Titan Pharmaceuticals trading resumes

09:33 EDT Titan Pharmaceuticals trading halted, volatility trading pause

09:30 EDT Lowe's sees FY24 capital expenditures $2B - Sees FY24 tax rate 24.5%. Says has strong product lineup ready for the fall. Says Pros backlogs remain healthy. Says expects operating margin rate for second half in line with prior year. Says DIY sales are concentrated in bigger ticket sales. Says not necessarily losing share in DIY. Says DIY big ticket discretionary spend impact largely a microenvironment issue. Comments and guidance taken from Q2 earnings conference call.

09:21 EDT Thumzup welcomes Zoe's Vintique to Adtech platform - Thumzup Media Corporation welcomes Zoe's Vintique as one of its most recent advertising partners on its proprietary social media AdTech platform.The boutique prides itself on its curated selection of one-of-a-kind pieces from around the world. Customers will now have the unique opportunity to earn money by sharing their experiences at the vintage shop through the Thumzup app.

09:18 EDT Trimont to acquire Wells Fargo's non-agency third-party CMS business - Trimont has entered into a definitive agreement to purchase Wells Fargo's non-agency third-party Commercial Mortgage Servicing business, the largest servicer of CRE securitized debt in the U.S. The transaction, backed by Varde Partners, positions Trimont as the largest loan servicer, managing a combined $640 billion of loans in the United States, equivalent to approximately 11% of the U.S. commercial real estate lending market. Trimont primarily serves non-bank and alternative lenders, while CMS specializes in securitized debt products including CMBS conduit, SASB, CLOs, and Freddie Mac K-series. This acquisition enables Trimont to offer comprehensive servicing across all non-bank commercial real estate lending structures, including Master Servicing. Funding for the transaction will be provided by Varde Partners, a global alternative investment firm, which acquired and has owned Trimont through certain funds since 2015. Varde has over a decade of experience owning and developing real estate servicing platforms and is committed to its long-term investment in Trimont. The transaction is subject to customary closing conditions and is expected to be finalized in early 2025. Post-closing, Trimont will manage more than $715 billion in U.S. and international commercial real estate loans.

09:11 EDT Roche announces it will support response to mpox global health emergency - Roche announced that it is supporting the international response to the mpox global health emergency with its diagnostic tests developed for mpox, formerly known as monkeypox. Mpox, a viral disease that can spread easily between people and from infected animals, was declared a Public Health Emergency of International Concern by the World Health Organization, WHO. Globally, Roche is partnering with governments, healthcare providers and organisations dedicated to combating the mpox outbreak. More specifically, Roche is actively working with its partners to enhance mpox laboratory capacity worldwide. In addition, Roche provides training for laboratories across the African continent at the Roche Scientific Campus in South Africa, as well as locally.

09:10 EDT Vision Marine Technologies commences exchange offer - The Company additionally announced today that it has commenced an exchange offer relating to its outstanding private placement of Series A Convertible Preferred Shares and warrants issued by the Company on December 21, 2023. The purpose of the Exchange is to simplify the Company's capital structure and reduce the potential dilutive impact of the Warrants. The Company is offering to all holders of the Warrants the opportunity to receive twice the number of warrant shares equal to shares of the Company's common shares, no par value per share and a number of pre-funded common share warrants of the Company in exchange for each outstanding Warrant tendered by the Warrant holder and exchanged pursuant to the Exchange. Pursuant to the Exchange, the Company is offering up to an aggregate of 5,650,284 common shares in exchange for the Warrants.

09:08 EDT Juventus Football Club announces Fortinet as its official cybersecurity partner - Juventus Football Club and Fortinet have signed a sponsorship agreement through which Fortinet becomes the new Official Cybersecurity Partner for the next two seasons, through 2026. Juventus has also chosen Fortinet's industry-leading Security Fabric platform to reduce complexity and streamline the identification and resolution of network and security issues across the club's facilities.

09:07 EDT Apollo Global's TeleVox expands Agent Chat functionality - TeleVox is solving the challenge of overworked healthcare call centers and frustrated patients waiting on hold with the expansion of Agent Chat, which utilizes a secure, web-based experience to connect patients to a staff member who can address the patient's needs. Patients calling into healthcare offices spend an average of eight minutes on the phone with 63 percent of calls being transferred, wasting both time and resources. With Agent Chat, a secure conversation is initiated to quickly connect a patient to the healthcare facility, greatly reducing call volumes and wait times while also improving staff productivity and Net Promoter Scores.

09:05 EDT Syla Technologies board declares interim dividend of Y100 per share - SYLA Technologies Board of Directors meeting on August 16, 2024, resolved that the Company will pay an interim dividend of Y100 per common share with a record date for ADR holders of June 30, 2024, to shareholders.

09:04 EDT Medtronic expects pressure from FX to decline in 2H25 - Says M&A strategy targeted to highest growth areas.

09:03 EDT Ageagle announces delivery of eBee VISION drones to French Army - AgEagle Aerial Systems announces the delivery of the first 20 eBee VISION systems to its reseller for French Army surveillance operations. Each system consists of an eBee VISION UAV, ground control systems, comms and antenna package, and a tactical backpack unit. The units delivered pursuant to this purchase order will be followed by a comprehensive spares package, with the total order valued at $3.4M.

09:02 EDT Honest Company enters collaboration with Lil' Libros - The Honest Company announced its second collaboration with Lil' Libros, a publishing brand founded by two Latina mothers, Patty Rodriguez and Ariana Stein, on a mission to introduce bilingual literature and the American Latine culture through picture books. This unique partnership brings to life vibrant, culturally inspired product prints inspired by Alebrijes; fantastical creatures deeply rooted in Mexican folk art. Exclusively available at Walmart as of August 1, 2024, the new product line features baby-friendly, bilingual images designed to engage and educate young minds. These colorful prints celebrate the richness and diversity of Latin American culture, aligning perfectly with both brands' dedication to creating meaningful and educational experiences for families.

08:52 EDT Gladstone Commercial executes five-year lease renewal at Ohio property - Gladstone Commercial Corporation has executed a 5-year lease extension with Morgan Stanley Smith Barney Financing LLC through December 31, 2030 for 72,301 square feet of its 101,869 square foot office building located at 4343 Easton Commons in Columbus, Ohio. This lease renewal continues Morgan Stanley's existing tenancy that began in 2008.

08:49 EDT Omniq announces collaboration agreement with SHVA - OMNIQ announces that it has concluded the process and is poised for the signing of a collaboration agreement with SHVA, Israel's premier payment processing company. This partnership marks a significant milestone in OMNIQ's strategic expansion within the fintech industry. "This partnership marks a major advance for OMNIQ in the fintech sector," said Shai Lustgarten, CEO of OMNIQ. "Collaborating with SHVA, a leader in payment processing, aligns perfectly with our strategic plan to expand our fintech capabilities and enhance customer experiences through innovative technology."

08:48 EDT Avinger announces commercial launch of Pantheris LV atherectomy device - Avinger announced full commercial launch of the Pantheris LV image-guided directional atherectomy system. With the initiation of full commercial launch, all current and prospective accounts can now order the Pantheris LV device, a line extension of the first and only image-guided atherectomy device for the treatment of peripheral artery disease. Prior to full commercialization, Avinger conducted a limited launch at 16 clinical centers in the United States, with over 20 interventional physicians treating patients with the new device. This initial clinical experience validated the key design enhancements incorporated into Pantheris LV, including higher speed plaque excision for efficient removal of challenging occlusive tissue, and multiple design elements to streamline user-operation. These new features include a proprietary jog mechanism for plaque apposition, an advanced guidewire management system, and design enhancements for improved tissue packing and removal.

08:47 EDT Nano Nuclear Energy purchases facility in Oak Ridge, Tennessee - NANO Nuclear Energy announced that it has purchased a 1.64-acre land package in the historic Heritage Center Industrial Park in Oak Ridge, Tennessee. The purchase includes a 14,000 sq. ft., 2-story building to house NANO Nuclear's Nuclear Technology Headquarters. "Oak Ridge holds a legendary place in the history of America's nuclear innovation. Speaking for our entire scientific and engineering team, we are thrilled to establish and grow our technology headquarters in such a significant location," said James Walker, Chief Executive Officer and Head of Reactor Development of NANO Nuclear Energy.

08:46 EDT EzFill announces strategic transactions, debt restructuring - EzFill Holdings announced a series of strategic transactions aimed at bolstering its financial position and regaining compliance with Nasdaq listing requirements, subject to Nasdaq confirmation. The transactions, which have closed, leave the Company essentially debt free except for a small outstanding loan, current payables, and certain vehicle financing; and augment the Company's cash position. The debt conversions alone are expected to eliminate an estimated $1.2 million in annual interest expense. EzFill has entered into a Stock Purchase Agreement with NextNRG Holding Corp. Under this agreement, Next purchased 140,000 shares of EzFill's Series B Convertible Preferred Stock for $10.00 per share, resulting in a total investment of $1,400,000. Separately, EzFill has executed two significant debt-to-equity conversion agreements which converted approximately $13.5 million of debt into equity. In the first, certain promissory notes issued by EzFill to Next were exchanged and converted into 3,525,341 shares of common stock of EzFill at the Nasdaq minimum price of $2.78 per share. In addition, certain promissory notes issued by EzFill to AJB Capital Investments, were exchanged and converted into 363,000 shares of Series A Preferred stock in EzFill. In conjunction with these agreements, EzFill has filed certificates of designation for 513,000 shares of Series A Preferred Stock and 150,000 shares of Series B Convertible Preferred Stock with the Delaware Department of State.

08:44 EDT PainReform announces safety profile for PRF-110 in Phase 3 study - PainReform announced encouraging early safety results from its ongoing Phase 3 bunionectomy study of PRF-110, the Company's proprietary post-surgical pain formulation. The study, which has now completed full enrollment with a total of 443 patients across eight clinical sites in the United States, is designed as a randomized, double-blind, placebo-controlled trial to evaluate the efficacy and safety of PRF-110 in patients undergoing bunionectomy, a common outpatient surgical procedure. Initial safety data from the study revealed a low incidence of adverse events, averaging just one per subject.

08:44 EDT AmpliTech's AGTGSS division signs MOU for initial private 5G network deployment - AmpliTech Group announced the signing of a Memorandum of Understanding, MOU, with a USA based IP Data Networking company to deploy a Private 5G Network in the state of California. AGTGSS announces this MOU which aims to initiate its first Private 5G Network deployment within the continental United States. This would mark a significant milestone in AGTGSS's commitment to delivering cutting-edge 5G telecommunications infrastructure solutions across the United States and globally.

08:42 EDT Atossa announces appointment of Parks as VP, Investor, Public Relations - Atossa Therapeutics (ATOS) announced the appointment of Michael Parks as Vice President, VP, of Investor and Public Relations. Parks brings nearly 30 years of investor relations and corporate communications experience working globally within the biopharmaceutical and healthcare industries. Prior to joining Atossa, Parks was Vice President of Investor Relations at PAVmed (PAVM)

08:41 EDT Webuy achieves $2.9M in sales within three days at NATAS Fair - Webuy Global generated a record $2.9 million in sales over three days at this year's NATAS Fair 2024, driven by its "Travel with Webuy" tour packages.

08:40 EDT Bio-Rad Labcorp announces Jon DiVincenzo as COO - Bio-Rad Laboratories (BIO )announced that Jon DiVincenzo will join the company as President and Chief Operating Officer, effective September 9 replacing Andy Last, who is retiring. DiVincenzo joins Bio-Rad from Labcorp Holdings (LH), a global provider of comprehensive laboratory services, where he held various global operational and commercial leadership roles across the company's several business units. Most recently, he served as Executive Vice President and President, Central Laboratories and International. Prior to LabCorp, Mr. DiVincenzo was President of the Environmental Health Division at PerkinElmer, a global company focused on diagnostics, life science research, food quality, environmental health and industrial testing. "We are thrilled to welcome Jon DiVincenzo as our President and Chief Operating Officer," stated Norman Schwartz, Bio-Rad's Chairman and Chief Executive Officer. "Jon brings to Bio-Rad over thirty years of industry experience across strategic, operational, and commercial organizations in both life science and clinical diagnostics. His extensive track record spans leadership roles in operations, marketing, and product development, which will be integral...

08:39 EDT Richtech Robotics announces ADAM installation at One Kitchen - Richtech Robotics (RR) announces the installation of its advanced robotic beverage system, ADAM, at a One Kitchen in a Rockford, IL Walmart (WMT). This milestone marks the second installation as part of a planned rollout across 240 One Kitchen locations in the U.S. One Kitchen restaurants feature multiple national and local brands using a single kitchen. The Rockford Walmart will also have a Richtech Robotics' Matradee L and DUST-E S installed. The installation is also part of Richtech Robotics' new commercial management venture, AlphaMax Management, which was formed to optimize the integration of the Company's robots into clients' businesses. As a wholly-owned subsidiary of Richtech Robotics, AlphaMax Management will be responsible for the entire commercial workflow of One Kitchen restaurants within Walmart, to better integrate the operation of robots with traditional restaurant operations, and to provide overall restaurant data analysis, digital marketing, and the integration of artificial intelligence applications.

08:37 EDT AgriFORCE granted Chinese patent for developmental automated growing systems - AgriFORCE Growing Systems announces the granting of Patent #CN 202080073940.7 titled, "Automated Growing Systems" by the China National Intellectual Property Administration. The patent follows the grant of the corresponding U.S. patent announced in June 2024 and adds to the Company's global intellectual property portfolio connected to agriculture and agribusiness. Company CEO, Jolie Kahn, stated, "The fully enclosed nature of our patented trussed greenhouses enables us to create microclimates in climates that may not be conducive to certain plant growth. When combined with our proprietary automated growing system we believe the potential for agricultural innovation - as well as innovation beyond the agricultural space - will help drive long-term shareholder value for all our stakeholders."

08:37 EDT Neuronetics announces two-year anniversary of NeuroStar University - Neuronetics announces the two-year anniversary of NeuroStar University. This milestone will be celebrated with a special event held at the NSU training center in Charlotte, North Carolina, showcasing the profound impact of NSU's pioneering training programs on pioneering new standards in patient care and responsiveness.

08:35 EDT Craig Technologies awards Sidus Space $2M deal for U.S. Navy propulsion program - Sidus Space announces its selection by Craig Technologies for the manufacturing of two leet Interactive Display Equipment FIDE Pre-production Unit Main panels for Bechtel Plant Machiner BPMI n support of a critical U.S. Navy program. This significant subcontract, valued at $2M , marks the third time Sidus Space has been chosen as a subcontractor for this customer. Under the new agreement, Sidus Space will leverage its state-of-the-art facilities and experienced team to manufacture, assemble, test, and deliver the FIDE panel trainers for Craig Technologies who is leading the design phase of the two panels. "Sidus Space is currently manufacturing thirteen (13) Propulsion Plant Trainers and had previously manufactured a related U.S. Navy trainer system. Our repeat engagements are a testament to the exceptional quality and reliability of our services. This contract reinforces our commitment to delivering superior products that meet the rigorous standards of the defense sector. Our team is dedicated to contributing to the advancement of national defense capabilities through innovative mission critical technology," said Carol Craig, CEO of Sidus Space.

08:24 EDT Medtronic says at 'front end' of many new product cycles - Expects to launch new technologies in coming quarters. Says continues to make progress on margin improvement activities. Says capital allocation policy has not changed. Says will continue to focus on "tuck-in M&A." Expects operating margins to expand in FY25. Expects EPS growth to accelerate in 2H25. Comments taken from Q1 earnings conference call.

08:21 EDT Lucid Diagnostics' EsoGuard cancer diagnosis test highlighted in publication - Lucid Diagnostics announced the peer-reviewed publication of an analytical validation study of its EsoGuard Esophageal DNA test for the diagnosis of esophageal precancer and esophageal adenocarcinoma on samples collected non-endoscopically using Lucid's EsoCheck Esophageal Cell Collection Device. The manuscript has been published in the peer-reviewed journal Diagnostics. The publication details studies demonstrating "excellent analytical performance" of the EsoGuard assay on samples collected with EsoCheck, including 89% analytical sensitivity, 100% analytical specificity, 96% analytical accuracy, and 100% inter- and intra-assay precision.

08:19 EDT San Juan Basin Royalty Trust declaring no cash distribution in August - San Juan Basin Royalty Trust will not declare a monthly cash distribution to the holders of its Units of beneficial interest due to excess production costs for the Trust's subject interests during the production month of June, as well as low natural gas pricing. Excess production costs for this reporting period are due primarily to significant lease operating expenses and capital expenditures associated with Hilcorp San Juan L.P.'s 2024 capital project plan. Hilcorp will charge the excess production costs of approximately $8,456,506 gross, $6,342,379 net to the Trust, to the next month's distribution. No cash distributions will be made by the Trust until future net proceeds are sufficient to pay then-current Trust liabilities and replenish cash reserves. Interest income received by the Trust in the amount of $6,302 will be applied to cover a portion of this month's Trust administrative expenses, with cash reserves utilized to pay the remaining administrative expenses. Total cash reserves were $1.8M as of April 30. Prior to any future distributions to Unit Holders, the Trustee plans to replenish the cash reserves and continue to increase the cash reserves to $2.0M. These revenues and costs (along with all costs) are the subject of the Trust's ongoing comprehensive audit process by the Trust's professional consultants and outside counsel.

08:14 EDT Brunswick announces organizational changes - Brunswick Corporation is announcing the following changes to its organization that are aimed at further broadening the experience of its senior leadership team. Aine Denari is named Executive Vice President and President, Navico Group, and Brunswick Chief Technology Officer. Denari was previously President, Brunswick Boat Group, a role she assumed in October 2020. In her new and expanded role, Denari will lead the next phase of evolution of the Navico Group and be responsible for Brunswick's technology strategy and advanced development activities, including maintaining the leadership of autonomy programs and assuming responsibility for the Boating Intelligence DesignLab at the University of Illinois. Brenna Preisser is named Executive Vice President and President, Brunswick Boat Group, succeeding Denari. Since January 2019, Preisser has been Executive Vice President and President, Business Acceleration, the division housing Freedom Boat Club, Boateka, and Brunswick's financial services and related businesses. She will now be responsible for Brunswick's portfolio of 18 leading boat brands, including Boston Whaler, Sea Ray, Bayliner, Lund, Harris, Quicksilver, and Princecraft. Will Sangster is promoted to Senior Vice President and President, Business Acceleration, succeeding Preisser, and will be responsible for the continued growth of the exciting portfolio of businesses within the division. Sangster was most recently President of Mercury Marine in EMEA, a position he assumed in October 2021, and prior to that he spent 14 years with Brunswick in a number of international leadership positions including as the head of Mercury Marine's ANZP region. Denari, Preisser, and Sangster will assume their new roles immediately. Brett Dibkey who preceded Denari as President, Navico Group will leave the company at the end of the August after assisting with the transition.

08:13 EDT GCT Semiconductor signs MOU with tier one telcom supplier, no terms - GCT Semiconductor Holding announced the execution of a memorandum of understanding MOU with a tier one worldwide infrastructure and terminal provider or the "Tier One Supplier" to collaborate on the development of Fixed Wireless Access,FWA, technology using GCT's 5G solutions including modem chipset and RFIC. The company expects to close a definitive agreement before the end of 2024. "With the continued 5G network expansion around the globe, there is a strong demand for faster and high-performing FWA technology and 5G devices," said John Schlaefer, CEO of GCT. "We are excited to continue our relationship with this key customer and look forward to working closely together as they roll out their 5G offering with GCT chipsets in 2025." The MOU extends GCT's existing relationship with this Tier One Supplier to include 5G chipsets, and collaboration on developing unique performance-enhancing features for FWA devices. The Company expects the launch of FWA devices related to this activity to commence in the second half of 2025.

08:12 EDT Bragg Gaming expands partnership with Caesars to Pennsylvania, Ontario - Bragg Gaming (BRAG) confirmed the launch of its newest games and Remote Gaming Server, or RGS, technology with Caesars Digital (CZR) in both Pennsylvania and Ontario. The launch marks the expansion of Bragg's existing partnership with Caesars Digital, following earlier launches in New Jersey and Michigan respectively, doubling the number of states/provinces in which Bragg content is offered on Caesars Palace Online Casino and Caesars Sportsbook & Casino. The expansion also deepens the partnership between the two companies.

08:11 EDT Ekso Bionics announces receipt of initial CMS reimbursement for Ekso Indego - Ekso Bionics Holdings announced that the Medicare program has, through the Centers for Medicare & Medicaid Services', CMS, regional Durable Medical Equipment Medicare Administrative Contractors completed claims processing and remitted a lump sum payment for Ekso Indego Personal. The amount paid was based on the $91,032 reimbursement level established for Healthcare Common Procedures Coding System, HCPCS, code K1007, which became effective on April 1, 2024. HCPCS K1007 can be used by other public health insurance programs as well as private payers. This marks the completion of the first reimbursement process for Medicare beneficiaries since Ekso Bionics received final payment determination for Ekso Indego Personal.

08:09 EDT Avadel announces results of post-hoc analysis on Phase 3 REST-ON trial - Avadel Pharmaceuticals announced the publication of results of a post-hoc analysis from the completed pivotal Phase 3 REST-ON clinical trial demonstrating greater weight loss in patients who received LUMRYZ compared with placebo. The paper, titled "Weight Loss With Once-nightly Sodium Oxybate for the Treatment of Narcolepsy: Analysis From the Phase III Randomized study Evaluating the efficacy and SafeTy of a ONce nightly formulation of sodium oxybate Trial," was published online in Clinical Therapeutics. Results of the post-hoc analysis, which evaluated the effect of LUMRYZ treatment on weight in adults with narcolepsy and further characterized participants experiencing greater than5% weight loss, showed: Participants who received LUMRYZ lost a mean of 1.3 kg from baseline to week 13. In contrast, those receiving placebo experienced a mean weight gain of 0.2 kg. A significantly higher proportion of study participants receiving LUMRYZ experienced greater than or equal to5% weight loss than those who received placebo. A significant reduction in BMI was observed after 13 weeks of treatment with LUMRYZ versus placebo, with a between-group difference in least squares mean change from baseline of -0.59 kg/m2. In the weight loss group, participants shifted from obese into overweight, and from overweight into normal weight during this trial; no participants were underweight.

08:08 EDT Bannix Acquisition announces monthly extension to complete business combination - Bannix Acquisition announced that its board of directors has decided to extend the date by which Bannix must consummate an initial business combination from August 14, 2024 for an additional month, to September 14, 2024. As previously disclosed, at an annual meeting of its stockholders held on March 8, 2024, Bannix' stockholders voted in favor of a proposal to amend Bannix's Amended and Restated Certificate of Incorporation to provide Bannix with the right to extend the Deadline Date up to six times for an additional one month each time until September 14, 2024. Also as previously announced, if an Extension is implemented, the sponsor of Bannix, Instant Fame, or its designees will deposit into the trust account, as a loan, the lesser of $25,000 and $0.05 for each share that is not redeemed in connection with the annual meeting. On August 15, 2024, the Board, at the request of the Sponsor, decided to implement the eighteenth Extension and to extend the Deadline Date for an additional month to September 14, 2024.

08:08 EDT Amneal Pharmaceuticals receives FDA approval for Propofol Injectable Emulsion - Amneal Pharmaceuticals announced that it has received abbreviated new drug application, or ANDA, approval from the FDA for Propofol Injectable Emulsion USP, 200 mg/20 mL, 500 mg/50 mL and 1,000 mg/100 mL, single-dose vials.

08:07 EDT FuelCell announces special stockholder meeting - FuelCell Energy plans to hold a special meeting of its stockholders on October 31, 2024 to consider and vote on a proposal to authorize the Company's Board of Directors to effect a reverse stock split of the Company's common stock through an amendment to the Company's Certificate of Incorporation, as amended. Holders of record of the Company's common stock as of the close of business on September 10, 2024 will be entitled to receive notice of and to vote at the Special Meeting. Details regarding the Special Meeting will be made available to stockholders at a later date in a proxy statement to be filed by the Company with the Securities and Exchange Commission.

08:05 EDT CPI Aerostructures appoints Passarello as CFO - CPI Aerostructures (CVU) announced that it has appointed Philip Passarello to the position of Chief Financial Officer. Prior to joining CPI Aero, Passarello served as Vice President of Finance for TTM Technologies (TTMI)

08:04 EDT Jayud Global Logistics to provide supply chain solutions for iMile - Jayud Global Logistics announces a strategic partnership with iMile, a leader in logistics and last mile delivery services for emerging markets such as the United Arab Emirates and the Kingdom of Saudi Arabia. This collaboration is set to streamline logistics for iMile by providing comprehensive supply chain solutions across China, encompassing air, sea, land, and customs services.

08:04 EDT Dayforce launches Dayforce Learning experience - Dayforce announced the launch of a new Dayforce Learning experience. Transforming learning and development for the new era of work, Dayforce Learning helps address the growing expectations of the modern workforce who want to stay current, upskill, and achieve their career aspirations. Embedded within the single, mobile-first Dayforce platform, Dayforce Learning will help equip organizations with the learning and development tools necessary to drive effective outcomes and succeed.

08:01 EDT Hollister unveils Collegiate Graphics Shop - Hollister Co. is rolling out its Collegiate Graphics Shop just in time for the back-to-school and fall sports seasons. The 67-piece collection is rooted in quality basics including crewneck sweatshirts, hoodies and tees, touting vintage-inspired university logos and graphics and represents more than 30 universities across the United States. The Collegiate Graphics Shop includes tees, crewnecks, hoodies and hats, in sizes Women's XXS-XXL and Men's XS-XXL, ranging from $29.95 to $59.95.

07:52 EDT Vital Farms appoints Joe Holland as CSCO - Vital Farms (VITL) has hired Joe Holland as Chief Supply Chain Officer beginning on September 1, 2024. He will lead Vital Farms' diversified supply chain team, including its egg washing and packing facility, Egg Central Station, in Springfield, Missouri, its forthcoming facility in Seymour, Indiana, and dairy operations for its growing butter business. In the newly created CSCO role, Mr. Holland will lead Vital Farms' Supply Chain and Logistics, Production Operations, Food Safety Quality Assurance, Dairy Operations, and Integrated Business Planning teams. Most recently, Mr. Holland served as the Executive Vice President of Operations and Supply Chain at Curaleaf Holdings (CURLF). Mr. Holland will assume many of the responsibilities previously held by Jason Dale, who has served as Vital Farms' COO since 2019. Mr. Dale will remain in an advisory role with the company through the end of 2024.

07:48 EDT State Street in pact with Taurus to enhance the digital investment lifecycle - State Street Corporation and Taurus, a firm in digital asset infrastructure, announced a strategic agreement that will deliver trusted and reliable digital assets capabilities for State Street Bank and Trust Company clients. The agreement will further enhance State Street Digital Asset Solutions, which seeks to provide an integrated business and operating model that supports the digital investment lifecycle. "The collaboration with Taurus underscores our ongoing commitment to further establishing ourselves as leaders in this growing asset class, and this important announcement only enhances our ambition to deliver to our clients an amazing digital asset experience," said Donna Milrod, State Street's chief product officer and head of Digital Asset Solutions. "We are excited to be working with Taurus as we continue to elevate our digital asset capabilities and deliver the innovative solutions our clients have been seeking." The collaboration comes at a time when institutional interest in digital assets is at an all-time high. State Street remains committed to providing its clients with best-in-class solutions for this emerging space.

07:47 EDT Jacobs wins program management extension for DC streetcar project - Jacobs was awarded an extension as program management consultant for the District Department of Transportation DC Streetcar. Launched five years ago to expand transit service in the nation's capital, the 2.4-mile DC Streetcar route serves a corridor of mixed-use development. As program management consultant, Jacobs supports DDOT's program implementation, including technical assistance; general engineering support; and stakeholder engagement with utilities, residences and businesses. The two-year extension expands Jacobs' scope of work to include oversight and management of operations and maintenance activities, on-site engineering services, safety and security planning and external communications.

07:35 EDT Telomir Pharmaceuticals's Telomir-1 featured in local ABC exclusive - Telomir Pharmaceuticals announced that its novel small molecule, Telomir-1, was recently featured in an exclusive local ABC television news segment highlighting promising "age reversal" outcomes in two senior dogs. The use of Telomir-1 in these two dogs was observed by Telomir's special advisor Dr. Michael Roizen, the former Chief Wellness Officer of the Cleveland Clinic and a leader in age-related medicine. In this small compassionate use program, remarkable improvements in the health and vitality of the dogs after treatment with Telomir-1 was noted, offering a glimpse into the potential future applications for humans. In the segment, "ABC7 Exclusive: New study reveals promising results for age reversal pill on dogs," the transformative potential of Telomir-1 was showcased through the stories of Zeus and Benson, two senior dogs from Donte's Den rescue organization in Myakka City, Florida. After being treated with Telomir-1, both dogs exhibited significant improvements in their health conditions. Zeus, a 12-year-old German Shepherd, showed complete remission of terminal cancer, while Benson, a 12-year-old Newfoundland suffering from severe arthritis, regained his mobility, leading to what caretakers described as a miraculous recovery.

07:17 EDT J.B. Hunt board authorizes repurchase of $1B of company's common stock - In a regulatory filing yesterday, J.B. Hunt stated: "On August 16, 2024, our Board of Directors adopted a new share repurchase program authorizing the repurchase of $1 billion of the company's common stock. The specific timing and amount of the repurchases will vary based on market conditions, cash flows, securities law limitations and other factors. The repurchase program has no stated expiration date but may be suspended or discontinued at any time without prior notice. This new repurchase program will begin after the completion of the company's existing $500 million repurchase program, which had $163 million remaining available and uncommitted at June 30, 2024." Reference Link

07:13 EDT Signal Gold announces assay results from drilling program at Goldboro - Signal Gold announced further assay results from its exploration drilling program at the western extension of the Goldboro Deposit at the Goldboro Project in Nova Scotia. These results are part of the recently completed diamond drilling program that comprised 5,179 metres of drilling from 26 holes and was designed to target near-surface mineral resource potential immediately west of the existing Goldboro Deposit with the goal of delineating additional open-pit Mineral Resources. These results are in addition to the high-grade intercepts previously announced on July 24, 2024, which included 21.27 grams per tonne over 5.0 metres and 23.37 g/t gold over 1.3 metres. The recent assay results from a further ten drill holes of the program continued to intersect multiple high-grade zones of gold mineralization along with 12 occurrences of visible gold. Selected composited highlights from drilling completed to date include: 17.97 g/t gold over 2.5 metres in drill hole BR-24-450, including 87.15 g/t gold over 0.5 m; 19.00 g/t gold over 2.4 metres in drill hole in drill hole BR-24-449, including 37.88 g/t gold over 1.0 metre, and including 14.31 g/t gold over 0.5 metres; 12.57 g/t gold over 1.5 metres in drill hole BR-23-453, including 31.34 g/t gold over 0.5 metres; 25.82 g/t gold over 0.6 metres in drill hole BR-24-448; 18.69 g/t gold over 0.5 metres in drill hole BR-24-449;10.33 g/t gold over 0.5 metres in drill hole BR-24-451; and 10.32 g/t gold over 0.5 metres in drill hole BR-24-452. "We are excited by these drill results immediately to the west of the Goldboro Deposit which continue to demonstrate the potential for additional open pit Mineral Resources outside the current deposit area at the Goldboro Project. The high-grade nature of these drill results, along with previously reported drilling west of the Goldboro Deposit, outline a robust system of gold mineralization and demonstrate continuity. We look forward to reporting additional assays from the drill program as they become available. There is strong growth and scale potential at the Goldboro Project, and we continue to achieve important project permitting milestones, including the recent granting of the Mineral Lease and the receipt of the Crown Land Lease and Licence Letter of Offer," said Kevin Bullock, President and CEO, Signal Gold Inc.

07:08 EDT Exact Sciences: 1st patient enrolled in MCED Falcon Registry RWE study - Exact Sciences announced that the first patient has joined its Multi-Cancer Early Detection MCED Falcon Registry Real-World Evidence RWE study at Baylor Scott & White, the primary study site and largest not-for-profit health system in Texas. The multi-site study will enroll up to 25,000 patients, evaluating the clinical performance, patient and provider experience, and psychological impact of MCED testing over a five-year period. Endeavor Health, a Chicago-area health system serving more than 1.4M patients, will start enrolling patients this fall. The U.S. Food and Drug Administration FDA recently authorized an investigational device exemption IDE for the Exact Sciences MCED test, allowing its use in the Falcon Registry. This study will provide valuable insight to further inform the development and commercialization of the company's future MCED test and support discussions with regulatory agencies, payers, and guideline bodies..."Implementing MCED testing and advancing preventative genomics are crucial steps in addressing the 'last mile' problem in health care," said Peter Hulick, M.D., the Janardan D. Khandekar, M.D., chair of personalized medicine and the director of the Mark R. Neaman Center for Personalized Medicine at Endeavor Health. "The Falcon Registry is a pivotal research study to meet the real-world challenges of implementation and aligns with the broader vision of the Davis Family Center for Preventive Genomics at Endeavor Health, which is to assist patients, their families, and caregivers in making better-informed decisions about early diagnosis, prevention strategies, and personalized treatment options." .

07:07 EDT Xortx Therapeutics announces presentation at ASN - Kidney Week 2024 - XORTX Therapeutics announces the acceptance of an abstract submitted to the American Society of Nephrology, ASN. The abstract entitled "Xanthine oxidase in rats, mice and humans with polycystic kidney disease" was reviewed by the ASN review panel for scientific merit and novel discoveries. The study was conducted at the University of Colorado in the independent laboratory of Dr. Charles Edelstein and was sponsored by XORTX and will be presented during the Session Title: Genetic Diseases: Cystic - Therapeutic Investigations and Prognosis. The aim of the study was to gain insight into whether increased xanthine oxidase, XO, activity results in cyst growth, XO activity was measured in PCK1 rats, PKD1/RC mice and 34 patients from the HALT-PKD Clinical study.

07:05 EDT Eli Lilly announces topline results from SURMOUNT-1 study - Eli Lilly announced topline results from the SURMOUNT-1 three-year study evaluating the efficacy and safety of tirzepatide once weekly for long-term weight management and delay in progression to diabetes in adults with pre-diabetes and obesity or overweight. Weekly tirzepatide injections significantly reduced the risk of progression to type 2 diabetes by 94% ii among adults with pre-diabetes and obesity or overweight compared to placebo. Additionally, treatment with tirzepatide resulted in sustained weight loss through the treatment period, with adults on the 15 mg dose experiencing a 22.9% ii average decrease in body weight compared to 2.1% for placebo in adults with pre-diabetes and obesity or overweight at the end of the treatment period. Tirzepatide was evaluated in 1,032 adults who had pre-diabetes at randomization and obesity or overweight for a treatment period of 176 weeks, followed by a 17-week off-treatment period. Results from the SURMOUNT-1 phase 3 study's primary analysis at 72 weeks in all participants were published in the New England Journal of Medicine in 2022. In a key secondary endpoint, tirzepatide led to a significant reduction in the risk of progression to type 2 diabetes in adults with pre-diabetes and obesity or overweight from baseline to week 176. For the efficacy estimandii, pooled doses of tirzepatide achieved significant results, demonstrating a 94% reduction in risk of progression to type 2 diabetes compared to placebo up to week 176. For the treatment-regimen estimandiii, pooled doses of tirzepatide resulted in a significant 93% reduction in risk of progression to type 2 diabetes compared to placebo up to week 176. In an additional key secondary endpoint, tirzepatide led to statistically significant weight reduction compared to placebo in adults with pre-diabetes and obesity or overweight from baseline to week 176. For the efficacy estimandii, adults taking tirzepatide achieved average weight reductions of 15.4%, 19.9% and 22.9% compared to placebo (2.1%) at week 176. For the treatment-regimen estimandiii, adults taking tirzepatide achieved average weight reductions of 12.3%, 18.7% and 19.7% compared to placebo at week 176. During the 17-week off-treatment follow-up period, those who had discontinued from tirzepatide began to regain weight and had some increase in the progression to type 2 diabetes, resulting in an 88% reduction in the risk of progression to type 2 diabetes compared to placebo. The overall safety and tolerability profile of tirzepatide over the 193-week study was consistent with the previously published primary results at 72 weeks in SURMOUNT-1 and other tirzepatide clinical studies conducted for chronic weight management. The most frequently reported adverse events were typically gastrointestinal-related and generally mild to moderate in severity. The most common gastrointestinal-related adverse events for patients treated with tirzepatide were diarrhea, nausea, constipation and vomiting. Tirzepatide, a GIP and GLP-1 receptor agonist, works by activating the two hormone receptors. GLP-1 is a regulator of appetite and caloric intake. Nonclinical studies suggest the addition of GIP may further contribute to the regulation of food intake. Tirzepatide decreases calorie intake, and the effects are likely mediated by affecting appetite. In addition, tirzepatide stimulates insulin secretion in a glucose-dependent manner. Tirzepatide increases insulin sensitivity in patients with type 2 diabetes mellitus and these effects can lead to a reduction of blood glucose. These topline results provide evidence for reduced risk of progression to type 2 diabetes and long-term maintenance of weight loss with tirzepatide in adults with pre-diabetes and obesity or overweight. Detailed results will be submitted to a peer-reviewed journal and presented at ObesityWeek 2024, which will take place November 3-6.

07:05 EDT Boralex announces closing of $95M financing for Temiscouata wind farm - Boralex announced the closing of a $95 million financing for the 52 MW Temiscouata II wind farm, located on public lands in the municipalities of Saint-Elzear-de-Temiscouata and Saint-Honore-de-Temiscouata, Quebec, and in operation since 2015. This financing was provided by Desjardins, as Sole Lender and Sole Arranger. The financing for the site comprises: An $85 million term loan, amortized over 11 years; A letter of credit facility, totaling $9.7 million, for guarantees under contracts with Hydro-Quebec and financing reserves; A significant portion of the long-term financing component bears interest at a rate fixed under an interest rate hedging arrangement. An ESG swap which includes a cash back, designed by Desjardins, to cover the debt's interest rate risk and to reward the achievement of ESG key performance indicators. Specifically, the measures monitored are CO2 emissions avoided by Boralex's renewable energy production worldwide and female representation in management positions.

07:03 EDT Climb Channel Solutions announce launch of MSP360 partnership - Climb Channel Solutions, a owned subsidiary of Climb Global Solutions, announced the launch of their partnership with MSP360, a backup and IT management software vendor. "We are thrilled to announce our new partnership with Climb Channel Solutions," said Brian Helwig, CEO of MSP360. "Their extensive reach and expertise in the IT channel will be instrumental in getting our industry-leading data protection and IT management solutions into the hands of more value-added resellers and managed service providers. This collaboration will empower us to deliver unparalleled reliability and peace of mind to a much wider audience, accelerating our mission to safeguard critical data for organizations of all sizes."

07:02 EDT Johnson & Johnson announces FDA approval of RYBREVANT plus LAZCLUZE - Johnson & Johnson announced that the U.S. FDA approved RYBREVANT plus LAZCLUZE for the first-line treatment of adult patients with locally advanced or metastatic non-small cell lung cancer with epidermal growth factor receptor exon 19 deletions or exon 21 L858R substitution mutations, as detected by an FDA-approved test.

06:54 EDT Elanco announces Credelio Quattro has moved to final FDA administrative review - Elanco Animal Health announced the U.S. Food and Drug Administration, FDA, has completed its review of all major and minor technical sections for Credelio Quattro, and the final 60-day administrative review is underway. "This is an exciting time at Elanco as we deliver a robust innovation portfolio that we believe will help transform animal care with solutions that go beyond today's market leaders," said Jeff Simmons, Elanco President and CEO. "Elanco expects to launch a potential blockbuster each of the next three quarters in large, fast-growing or new markets that are largely accretive to Elanco. We continue to expect $600 million to $700 million of innovation sales in 2025." The Company continues to expect Credelio Quattro to be positively differentiated and is seeking approval for indications that would give the broadest parasite coverage including fleas, ticks, heartworms and other internal parasites, like tapeworm. In addition to the regulatory process, the company is finalizing the manufacturing scale-up to optimize launch, targeted for the first quarter of 2025.

06:33 EDT Premier names Glenn Coleman as Chief Administrative and Financial Officer - Premier (PINC) announced that Glenn Coleman was unanimously appointed by the Board of Directors to serve as the Chief Administrative and Financial Officer of the company, effective November 11. Coleman will succeed Craig McKasson, who will retire on December 31, 2024, and will serve as a strategic advisor to the company through 2026. Coleman currently serves as Executive Vice President and CFO of Dentsply Sirona (XRAY).

06:05 EDT AstraZeneca reports Fasenra approved in China for severe eosinophilic asthma - AstraZeneca's Fasenra has been approved in China by the country's National Medical Products Association, or NMPA, for the maintenance treatment of patients 12 years of age and older with severe eosinophilic asthma, or SEA. Ruud Dobber, Executive Vice President, BioPharmaceuticals Business Unit, AstraZeneca said: "Today's approval is an important step forward in the treatment of severe asthma in China, which affects millions of patients. Those living with severe asthma will soon have access to Fasenra, which rapidly targets eosinophils, resulting in a significant reduction of asthma exacerbations and clinically meaningful symptom relief for patients."

06:02 EDT Solidion granted 20 patents on next-gen batteries during first 8 months of 2024 - Solidion Technology announced that an additional 20 U.S. patents have been approved and issued so far this year, adding to their best-in-class intellectual property portfolio. Solidion holds over 570 patents (issued and pending) globally, with 400+ in the United States and 170+ in various foreign jurisdictions. This strategic portfolio of patents covers key technologies for next-generation batteries for electric vehicles and energy storage systems. Notably, Solidion gained recognition by winning the prestigious R&D100 award in 2018 for their Silicon Anode Material, a testament to their innovation.

05:29 EDT Yirendai announces semi-annual dividend policy - The company said, "The Company is pleased to announce that the Board has approved a semi-annual dividend policy, reflecting our commitment to delivering value to our shareholders. Pursuant to the policy, the Board plans to declare semi-annual dividends at an amount equivalent to no less than 10% of the Company's anticipated net income after tax in each half year commencing from the first half of 2024. The determination to declare and pay such semi-annual dividends and the amount of dividends in any particular half year will be made at the discretion of the Board and will be based upon the Company's operations, earnings, cash flow, financial condition and other relevant factors that the Board may deem appropriate. The cash dividend for the first half of 2024, a payment of US$0.2 per American depositary share (the "ADS"), each representing two ordinary shares of the Company, par value US$0.0001 per share, is expected to be paid on or about October 15, 2024, to holders of the Company's ordinary shares and ADSs of record as of the close of business on September 30, 2024, Hong Kong time and New York time, respectively."

05:18 EDT Aurora Mobile enters strategic agreement with Zhongda Yingcai - Aurora Mobile announced that it has signed a strategic agreement with Zhongda Yingcai Network Education Technology. Leveraging Aurora Mobile's JPush intelligent push notification solution, the company will help Zhongda Yingcai's online education platform wangxiao.cn provide intelligent messaging services.